Nurse Practitioner in Oakley, CA Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Shirley Carrillo, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2109 Truman Ln, Oakley, CA 94561 Phone: 925-522-9689 |
Rebecca Maher, NP Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 2021 Main St, Oakley, CA 94561 Phone: 925-776-8200 |
Christina Loeliger, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2021 Main St, Oakley, CA 94561 Phone: 925-776-8200 Fax: 925-776-8260 |
Mrs. Charlotte Kirton, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5351 Lakespring Dr, Oakley, CA 94561 Phone: 510-943-2948 |
Maureen U Ezeigwe, Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 781 Westmoor Cir, Oakley, CA 94561 Phone: 903-954-0492 |
News Archive
BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD
BioSante Pharmaceuticals, Inc., announced today that the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous efficacy data, consultation with key opinion leaders (KOLs) in female sexual dysfunction, testosterone therapy and placebo effects, as well as a meeting with the U.S. Food and Drug Administration (FDA).
VIVUS disappointed with FDA Advisory Committee's vote on QNEXA for obesity treatment
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
Gene mutation causes Parkinson's disease in some families
An international research team, led by scientists at the National Institute on Aging (NIA), has discovered a gene, which when mutated, causes Parkinson's disease in some families.
Ligand's total revenues increase 37% to $16.0 million in first quarter 2014
Ligand Pharmaceuticals Incorporated today reported financial results for the three months ended March 31, 2014, and provided an operating forecast and program updates.
› Verified 5 days ago
Registered Nurse
Nurse Practitioner
Licensed Vocational Nurse
Physician Assistant